drugset / Trial / NCT03083119

Efficacy and Safety of Xuesaitong Soft Capsule for Coronary Heart Disease Unstable Angina

NCT03083119 ↗

Phase 2 Unknown 70 enrolled Jie Wang
RandomizedParallel-groupTriple-blindTreatment

Summary

In this study, typical cases of coronary heart disease are selected. They will be intervened by Xuesaitong soft capsules to investigate efficacy and safety for Coronary Heart disease.

Timeline

Start
2017-03-20
Primary completion
2017-04-20
Completion
2017-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Panax notoginseng saponins Traditional medicine (herbal / TCM) — —